Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis

BACKGROUND: To explore the significance of SAA in evaluating the severity and prognosis of COVID-19. METHODS: A total of 132 patients with confirmed COVID-19 who were admitted to a designated COVID-19 hospital in Wuhan, China from January 18, 2020 to February 26, 2020 were collected. The dynamic cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huan, Xiang, Xiaochen, Ren, Hongwei, Xu, Lingli, Zhao, Lisha, Chen, Xiaoqiong, Long, Hui, Wang, Qiang, Wu, Qingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of The British Infection Association. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141628/
https://www.ncbi.nlm.nih.gov/pubmed/32277967
http://dx.doi.org/10.1016/j.jinf.2020.03.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141628/
https://www.ncbi.nlm.nih.gov/pubmed/32277967
http://dx.doi.org/10.1016/j.jinf.2020.03.035

Ejemplares similares